ADVANZ Trademark

Trademark Overview


On Thursday, November 10, 2022, a trademark application was filed for ADVANZ with the United States Patent and Trademark Office. The USPTO has given the ADVANZ trademark a serial number of 97671247. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by Mercury Pharma Group Limited. The ADVANZ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus an...

Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer
advanz

General Information


Serial Number97671247
Word MarkADVANZ
Filing DateThursday, November 10, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and ServicesA full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations
Goods and ServicesMedical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 30, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMercury Pharma Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon EC4N7BL
GB

Party NameMercury Pharma Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon EC4N7BL
GB

Trademark Events


Event DateEvent Description
Wednesday, November 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 14, 2022NEW APPLICATION ENTERED
Thursday, January 19, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 18, 2023ASSIGNED TO EXAMINER
Thursday, January 19, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, January 19, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 19, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, February 16, 2023PRIORITY ACTION WRITTEN
Thursday, February 16, 2023PRIORITY ACTION E-MAILED
Thursday, February 16, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, May 16, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 16, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 27, 2023FINAL REFUSAL WRITTEN
Wednesday, September 27, 2023FINAL REFUSAL E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 24, 2023EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, October 24, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, October 24, 2023EX PARTE APPEAL-INSTITUTED
Tuesday, October 24, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 12, 2024ASSIGNED TO LIE
Tuesday, March 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 9, 2024EXPARTE APPEAL TERMINATED
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT